BRIEF published on 05/28/2024 at 22:36, 2 years 5 months ago Redishred Capital Corp. Announces Q1 2024 Results EBITDA Revenue Growth Acquisitions Q1 2024 Redishred
BRIEF published on 05/28/2024 at 22:36, 2 years 5 months ago Redishred Capital Corp. annonce ses résultats du premier trimestre 2024 Acquisitions Hausse Des Revenus BAIIA T1 2024 Redishred
BRIEF published on 05/28/2024 at 22:35, 2 years 5 months ago Volatus Releases Q1 2024 Financial Results and Provides General Corporate Update Revenue Growth Aerial Intelligence Q1 2024 Operational Achievements Volatus
BRIEF published on 05/28/2024 at 22:35, 2 years 5 months ago Volatus publie ses résultats financiers du premier trimestre 2024 et fournit une mise à jour générale de l'entreprise Hausse Des Revenus T1 2024 Volatus Renseignement Aérien Réalisations Opérationnelles
BRIEF published on 05/28/2024 at 22:35, 2 years 5 months ago Wilmington Eye Now Offering iDose(R) TR as a New Treatment Option to Reduce Eye Pressure in Patients With Ocular Hypertension and Open-Angle Glaucoma Medical Innovation Ocular Hypertension Wilmington Eye IDose TR Glaucoma Treatment
BRIEF published on 05/28/2024 at 22:35, 2 years 5 months ago Wilmington Eye propose désormais iDose(R) TR comme nouvelle option de traitement pour réduire la pression oculaire chez les patients souffrant d'hypertension oculaire et de glaucome à angle ouvert Innovation Médicale IDose TR Oeil De Wilmington Traitement Du Glaucome Hypertension Oculaire
BRIEF published on 05/28/2024 at 22:20, 2 years 5 months ago Birkenstock Refinances Loans and Cuts USD 50 Million in Debt Refinancing BIRKENSTOCK Deleveraging Financial Optimization Credit Facilities
BRIEF published on 05/28/2024 at 22:20, 2 years 5 months ago Birkenstock refinance ses prêts et réduit sa dette de 50 millions de dollars BIRKENSTOCK Désendettement Refinancement Optimisation Financière Facilités De Crédit
BRIEF published on 05/28/2024 at 22:20, 2 years 5 months ago NANOBIOTIX Présente de Nouvelles Données à l'ASCO 2024 Immunothérapie NANOBIOTIX NBTXR3 ASCO Phase 1
BRIEF published on 05/28/2024 at 22:20, 2 years 5 months ago NANOBIOTIX Presents New Data at ASCO 2024 Immunotherapy NANOBIOTIX NBTXR3 ASCO Phase 1
Published on 10/30/2026 at 23:35, 18 hours 3 minutes ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 18 hours 8 minutes ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 20 hours 51 minutes ago CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 22 hours 38 minutes ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 2 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/31/2026 at 16:35, 1 hour 3 minutes ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 18 hours 49 minutes ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 23:00, 18 hours 38 minutes ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 18 hours 38 minutes ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
